<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82847">
  <stage>Registered</stage>
  <submitdate>26/05/2008</submitdate>
  <approvaldate>4/06/2008</approvaldate>
  <actrnumber>ACTRN12608000287336</actrnumber>
  <trial_identification>
    <studytitle>Does exercise enhance mucociliary clearance in adults with cystic fibrosis?</studytitle>
    <scientifictitle>Exercise for mucus clearance in cystic fibrosis</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>cystic fibrosis</healthcondition>
    <conditioncode>
      <conditioncode1>Human genetics and inherited disorders</conditioncode1>
      <conditioncode2>Cystic fibrosis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treadmill exercise, speed and incline set to achieve an exercise intensity of 60% of each subject's peak VO2 for 20 minutes on one occasion. Peak VO2 measured on the day prior to randomisation.
Positive expiratory pressure (PEP). Subjects breath through a PEP device which provides an expiratory pressure at the mouth of 15-20cmH2O. Subjects breath through this device for 15 breaths, followed by the Forced Expiratory Techinique. This cycle is repeated six times in a 20 minute period on one occasion.
Control (resting breathing). Sitting quietly, relaxed breathing for 20 minutes on one occasion.</interventions>
    <comparator>Positive expiratory pressure (PEP). Subjects breath through a PEP device which provides an expiratory pressure at the mouth of 15-20cmH2O. Subjects breath through this device for 15 breaths, followed by the Forced Expiratory Techinique. This cycle is repeated six times in a 20 minute period on one occasion.
Control (resting breathing). Sitting quietly, relaxed breathing for 20 minutes on one occasion.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>mucociliary clearance, measured by inhaled radioaerosol</outcome>
      <timepoint>pre-intervention,
immediately post intervention,
1 hour post intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>subjective feeling of lung congestion, measured on a 10cm visual analogue scale</outcome>
      <timepoint>pre-intervention,
immediately post intervention,
1 hour post intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>subjective ease of expectoration, measured on a 10cm visual analogue scale</outcome>
      <timepoint>pre-intervention,
during intervention,
1 hour post intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>spirometry</outcome>
      <timepoint>pre-intervention,
1 hour post intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>diagnosed with cystic fibrosis,
stable clinical condition</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>previous lung transplant,
pregnant,
if participation resulted in the 5 year radiation does for volunteers being exceeded</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>concealed opaque envelopes</concealment>
    <sequence>random number generation, using a computer program</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2 / Phase 3</phase>
    <anticipatedstartdate>15/06/2008</anticipatedstartdate>
    <actualstartdate>8/08/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate>14/04/2011</actualenddate>
    <samplesize>15</samplesize>
    <actualsamplesize>15</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Prince Alfred Hospital</primarysponsorname>
    <primarysponsoraddress>Missenden Road
Camperdown NSW 2050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Australian Cystic Fibrosis Research Trust</fundingname>
      <fundingaddress>PO Box 254
North Ryde NSW 1670</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Sydney</fundingname>
      <fundingaddress>Research Office
A14 Main Quadrangle
University of Sydney 2006</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Sydney</sponsorname>
      <sponsoraddress>Research Office
A14 Main Quadrangle
University of Sydney 2006</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The trial completed recruitment and data collection in 2011. Results presented at the European Cystic Fibrosis Conference and the Australasian Cystic Fibrosis Conference in 2011. Manuscript under preparation.</summary>
    <trialwebsite />
    <publication>Dwyer T, Daviskas E, Zainuldin M, Verschuer J, Eberl S, Bye P, Mellis C, Alison J. "Effects of exercise and PEP on mucociliary clearance in adults with cystic fibrosis". 9th Australasian Cystic Fibrosis Conference, Melbourne, Australia. 2011:p15-16.

Dwyer T. Exercise for airway clearance. 34th European Cystic Fibrosis Conference, Hamburg, Germany. 2011 (invited speaker, no abstract).</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney South West Area Health Service</ethicname>
      <ethicaddress>Ethics Review Committee
Page 8
Royal Prince Alfred Hospital
Missenden Road
Camperdown NSW 2050</ethicaddress>
      <ethicapprovaldate>12/03/2008</ethicapprovaldate>
      <hrec>X08-0300</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Jennifer Alison</name>
      <address>Head of Discipline
Discipline of Physiotherapy
Faculty of Health Sciences
University of Sydney
PO Box 170
Lidcombe NSW 1825</address>
      <phone>(02) 9351 9371</phone>
      <fax />
      <email>jennifer.alison@sydney.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jennifer Alison</name>
      <address>Head of Discipline
Discipline of Physiotherapy
Faculty of Health Sciences
University of Sydney
PO Box 170
Lidcombe NSW 1825</address>
      <phone>(02) 9351 9371</phone>
      <fax />
      <email>jennifer.alison@sydney.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Tiffany Dwyer</name>
      <address>Respiratory Medicine
11 West
Royal Prince Alfred Hospital
Missenden Road
Camperdown NSW 2050</address>
      <phone>(02) 9515 5234</phone>
      <fax />
      <email>tiffany.dwyer@sydney.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jennifer Alison</name>
      <address>School of Physiotherapy
Faculty of Health Sciences
University of Sydney
East Street
Lidcombe NSW 2141</address>
      <phone>+61 2 93519371</phone>
      <fax />
      <email>jennifer.alison@sydney.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>